MedTrace Logo

A Study of the TransPyloric Shuttle™ (TPS™) for Weight Reduction in Obese Subjects

NCT01386905 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-03-12

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility of the TransPyloric Shuttle™ (TPS™) when used to treat obesity.

Conditions

Interventions

DEVICE

BAROnova™ TransPyloric Shuttle™ (TPS™)

Subjects will undergo an endoscopic procedure to deliver the TPS™ into the stomach. The TPS™ moves freely without any physical attachment or invasive anchoring to tissue to reduce gastric outflow.

Sponsors & Collaborators

  • BaroNova, Inc.

    lead INDUSTRY

Principal Investigators

  • George Marinos, MD · Gastric Balloon Australia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-03-31
Completion
2012-05-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01386905 on ClinicalTrials.gov